Altasciences

There has been a recent resurgence in the interest of using psychedelic therapeutic drugs as a potential treatment for mental health issues. The regulatory environment is constantly evolving and has eased some barriers to clinical research. If your organization is considering moving into early clinical development for therapeutic psychedelics, it helps to know a few facts about researching psychedelics to help your organization move smoothly to first in human clinical trials and beyond. How Psychedelics Are Made Generally, psychedelics are either naturally derived or synthetic. Psilocybin, mescaline, and DMT are all naturally occurring, while LSD is fully synthetic. Recent research includes the development of second-generation molecules that will hopefully confer the mental health benefits without potentially unwanted side effects. Types of Mental Health Issues Psychedelics Can Treat A growing body of research shows promise for psychedelics’ potential to treat depression, ... Continue reading →

If you hope to get reliable, robust data from clinical trials to better inform decision-making, your CRO will need proper handling of specimens obtained from trial participants and samples prepared for lab analysis. Their precise, timely treatment is vital to making go/no-go decisions for a new therapeutic drug. There must be a certainty to the data that comes from proper handling to give the highest accuracy of results to inform decisions. The quality of data depends on rigorous sample management. Integrity needs to be safeguarded at every step. A CRO partner conducting preclinical and clinical studies and providing bioanalytical services must ensure continuity of processes, knowledge sharing, and long-term storage of samples in a centralized location. Here is everything you need to know about choosing the right CRO for your sample management needs. Proper Collection and Storage Conditions There are many different sample types across preclinical studies and clinical trials. The CRO ... Continue reading →